To further validate our findings, we examined the presence of circulating antibodies against MBP in an independent cohort of sleeping sickness patients from DRC that included both patients with an active infection (“cases”) and samples obtained from patients posttreatment (“treated) (Fig 9D and S26 Data). The gene discussed is MBP; the disease is infection.